Skip to content

Ponoi II Management, LLC

Follow

13F filer, CIK 1746488, San Francisco, CA

Ponoi II Management, LLC reported $137,252,000 across 5 holdings for the quarter ended 2020-12-31, in a 13F-HR filed 2021-02-16.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-21-002046

Changes against Q3 2020 are not shown: it was a notice, with the holdings in another manager's report (0 positions on file), so every position would read as new.

Period
2020-12-31
Reported value
$137M
Holdings
5
Top 10 weight
100%
New
Sold out

Holdings, Q4 2020

Share positions as resolved from 13F-HR 0000950123-21-002046, largest first. % of portfolio is the value over $137,252,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
CONSTELLATION PHARMACEUTICALCONSTELLATION PHARMACEUTICALQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: 1,574,229 shares 1,574,229$45.3M33.03%
NGM BIOPHARMACEUTICALS INCNGM BIOPHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: 1,298,908 shares 1,298,908$39.4M28.67%
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: 685,011 shares 685,011$27.1M19.76%Timeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: 686,274 shares 686,274$22.6M16.44%Timeline
RAPT THERAPEUTICS INCRAPT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: 145,401 shares 145,401$2.87M2.09%

How Q4 2020 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-21-002046 base2021-02-16acceptance time not in the bulk data set